A new systematic review questions familiar menu categories and explains why measured chemistry and specific products deserve more attention.
New transfers must meet HB 4454, while OMMA allows qualifying existing dispensary inventory to remain. The distinction matters for operators and patients.
An October 19 negotiating position would bring more hemp plant parts into agricultural market rules. It is not a completed EU-wide legalization measure.
The North Shore dispensary will mark its grand opening with a ribbon cutting and an adults-only Halloween event at 181 Broadway.
SNDL’s October 27 earnings show a divide between its retail business and cannabis manufacturing, with record free cash flow carrying an important qualification.
Israel’s latest procedural step puts four Canadian producers in focus, while the distinction between an investigation and an imposed trade duty remains essential.
A small University of Auckland study will compare a cannabis oil with placebo over months, separating an important research question from claims of proven benefit.
The Canadian producer plans to expand output from existing facilities, with a lighting project bringing its combined capacity target forward to June 2027.
Minnesota’s next CanRenew round offers community restoration funding, with applications due December 15. The program does not finance cannabis business operations.
Aurora reports that Curaleaf’s application to halt its share-sale program was dismissed. Both companies continue to disagree over the proposed takeover’s value and process.